ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Subcutaneous Administration of Testosterone
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 1790" data-attributes="member: 3"><p>I guess we will soon see data on subcutaneous T injections</p><p></p><p>Antares Pharma, Inc. announced that the first patients have been dosed in a clinical study evaluating testosterone enanthate administered weekly by subcutaneous injection at doses of 50 mg and 100 mg via the VIBEX™ QuickShot™ auto injector device in testosterone deficient adult males. Up to 45 patients will be enrolled at approximately eight investigative sites in the United States. <a href="http://www.businesswire.com/news/home/20130916006053/en/Antares-Pharma-Announces-Patients-Dosed-VIBEX%E2%84%A2-QS" target="_blank">http://www.businesswire.com/news/home/20130916006053/en/Antares-Pharma-Announces-Patients-Dosed-VIBEX™-QS</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 1790, member: 3"] I guess we will soon see data on subcutaneous T injections Antares Pharma, Inc. announced that the first patients have been dosed in a clinical study evaluating testosterone enanthate administered weekly by subcutaneous injection at doses of 50 mg and 100 mg via the VIBEX™ QuickShot™ auto injector device in testosterone deficient adult males. Up to 45 patients will be enrolled at approximately eight investigative sites in the United States. [URL]http://www.businesswire.com/news/home/20130916006053/en/Antares-Pharma-Announces-Patients-Dosed-VIBEX%E2%84%A2-QS[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Subcutaneous Administration of Testosterone
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top